Your immune system is in charge of protecting your body against disease or other damaging foreign bodies.
Is there a way you can engineer your immune system to prevent or stop diabetes?
Diabetes is one of the most prominent diseases in society and is rapidly increasing with each new day. In fact, according to the American Diabetes Association, 25.8 million adults and children in the U.S. have diabetes, which accounts for 8.3 percent of the population.
Dr. Todd M. Brusko joins Dr. Mike to discuss if (and how) your immune system can be engineered to stop diabetes.
Selected Podcast
Engineering the Immune System to Stop Diabetes
Featured Speaker:
Todd M. Brusko, Ph.D., conducted his graduate training at the University of Florida College of Medicine in theInterdisciplinary Program in Biomedical Sciences.
While there, he was awarded the Graduate Fellowship for Outstanding Research Award for his work in the laboratory of the renown diabetologist, Mark A. Atkinson, Ph.D. He then went on to conduct his postdoctoral fellowship at the University of California, San Francisco (UCSF) under the mentorship of Jeffrey Bluestone, Ph.D.
Dr. Brusko's work at UCSF contributed to the first clinical trial employing regulatory T-cells as a potential treatment for type-1 diabetes. Dr. Brusko and his team of diabetes researchers at the University of Florida are dedicated to the development of safe and effective therapies to prevent and reverse type-1 diabetes.
His laboratory works in close collaboration with pediatric endocrinologists Drs. Michael Haller, M.D., and Desmond Schatz, M.D., to conduct mechanistic studies in ongoing clinical trials and generate novel avenues for therapeutic intervention.
Todd M. Brusko, Ph.D., conducted his graduate training at the University of Florida College of Medicine in theInterdisciplinary Program in Biomedical Sciences.While there, he was awarded the Graduate Fellowship for Outstanding Research Award for his work in the laboratory of the renown diabetologist, Mark A. Atkinson, Ph.D. He then went on to conduct his postdoctoral fellowship at the University of California, San Francisco (UCSF) under the mentorship of Jeffrey Bluestone, Ph.D.
Dr. Brusko's work at UCSF contributed to the first clinical trial employing regulatory T-cells as a potential treatment for type-1 diabetes. Dr. Brusko and his team of diabetes researchers at the University of Florida are dedicated to the development of safe and effective therapies to prevent and reverse type-1 diabetes.
His laboratory works in close collaboration with pediatric endocrinologists Drs. Michael Haller, M.D., and Desmond Schatz, M.D., to conduct mechanistic studies in ongoing clinical trials and generate novel avenues for therapeutic intervention.